Psychiatric Case Managers, Psychiatric Mental Health Nurses, Psychiatric Nurse Practitioners
Antipsychotics, Compliance, Injectables, Psychiatry, Psychotic Disorders, Recovery, Schizophrenia
1. | Evaluate the limitations of current strategies used in the management of schizophrenia and develop individualized, self-management programs that support mental health consumers in the recovery process |
1. | Evaluate the limitations of current strategies used in the management of schizophrenia and develop individualized, self-management programs that support mental health consumers in the recovery process |
TARGET AUDIENCE
This activity has been designed to meet the educational needs of psychiatric mental health nurses, psychiatric nurse practitioners, and psychiatric case managers.
This educational activity is co-provided by the American Psychiatric Nurses Association and Spire Learning.
DISCLOSURE OF CONFLICTS OF INTEREST
The American Psychiatric Nurses Association (APNA) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by APNA for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CE activity:
Mary D. Moller, DNP, ARNP, APRN, PMHCNS-BC, CPRP, FAAN, has disclosed that she does not have any relevant financial relationships specific to the subject matter of the content of the activity.
Mary Ann Nihart, MA, APRN, PMHNP-BC, PMHCNS-BC, has disclosed that she does not have any relevant financial relationships specific to the subject matter of the content of the activity.
Lisa Strimple-Padios has disclosed that she does not have any relevant financial relationships specific to the subject matter of the content of the activity.
The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CE activity:
The following APNA staff serve as clinical content reviewers and/or participate in planning CE activities in a manner that may affect content: Patricia Black, PhD, RN; Deborah Hobbs, PhD, RN, hereby state that they or their spouse do not have any financial relationships with any commercial interests related to the content of this CE activity of any amount during the past 12 months.
The following Spire Learning staff serve as clinical content reviewers and/or participate in planning CME/CE activities in a manner that may affect content: Kashemi D. Rorie, PhD; Jeanne Prater; Christine Kocienda hereby state that they do not have any financial relationships or relationships to products or devices with any commercial interests related to the content of this CE activity of any amount during the past 12 months. The spouse of Jeanne Prater, is an employee of Novo Nordisk and stockholder of Johnson & Johnson. The spouse of Christine Kocienda is a stockholder of Johnson & Johnson and Procter & Gamble.
Off-label Product Disclosure
This educational activity does not include the discussion of published and/or investigational uses of agents that are not indicated by the US Food and Drug Administration.
General Disclosure and Copyright Statement
The opinions expressed in this activity are those of the participating faculty and not those of the American Psychiatric Nurses Association, Spire Learning, or any manufacturers of products mentioned herein.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. This information is provided for general medical education purposes only and is not meant to substitute for the independent medical judgment of a healthcare professional regarding diagnostic and treatment options of a specific patient's medical condition. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
The American Psychiatric Nurses Association and Spire Learning reserve the right to cancel or modify the activity content, faculty, and activities if necessary.
ACCREDITATION STATEMENT
The American Psychiatric Nurses Association is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
CREDIT DESIGNATION
This sequential activity is approved for 0.75 continuing nursing education contact hours by the American Psychiatric Nurses Association.
Estimated time to complete: 45 minutes
Medium: Internet
HOW TO RECEIVE CREDIT
By reviewing the course content and successfully completing the post-test and evaluation, nurses are entitled to receive 0.75 continuing nursing education contact hours. A statement of credit will be available to print from your user history page.
Supported Browsers: Internet Explorer 8.0+ for Windows 2000, 2003, Vista, XP, Windows 7, Windows 8 Google Chrome 28.0+ for Windows, Mac OS, or Linux Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux Safari 5.0+ for Mac OSX 10.5 and above For video playback, install the latest version of Flash or Quicktime. |